EP1041882A4 - Transvascular delivery of a composition to an extravascular tissue of a mammal - Google Patents

Transvascular delivery of a composition to an extravascular tissue of a mammal

Info

Publication number
EP1041882A4
EP1041882A4 EP98966022A EP98966022A EP1041882A4 EP 1041882 A4 EP1041882 A4 EP 1041882A4 EP 98966022 A EP98966022 A EP 98966022A EP 98966022 A EP98966022 A EP 98966022A EP 1041882 A4 EP1041882 A4 EP 1041882A4
Authority
EP
European Patent Office
Prior art keywords
mammal
composition
extravascular tissue
transvascular delivery
transvascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98966022A
Other languages
German (de)
French (fr)
Other versions
EP1041882A1 (en
Inventor
Hansell H Stedman
Charles R Bridges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of EP1041882A1 publication Critical patent/EP1041882A1/en
Publication of EP1041882A4 publication Critical patent/EP1041882A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3613—Reperfusion, e.g. of the coronary vessels, e.g. retroperfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3659—Cannulae pertaining to extracorporeal circulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
EP98966022A 1997-12-19 1998-12-18 Transvascular delivery of a composition to an extravascular tissue of a mammal Withdrawn EP1041882A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6831797P 1997-12-19 1997-12-19
US68317P 1997-12-19
PCT/US1998/027072 WO1999031982A1 (en) 1997-12-19 1998-12-18 Transvascular delivery of a composition to an extravascular tissue of a mammal

Publications (2)

Publication Number Publication Date
EP1041882A1 EP1041882A1 (en) 2000-10-11
EP1041882A4 true EP1041882A4 (en) 2002-04-17

Family

ID=22081785

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98966022A Withdrawn EP1041882A4 (en) 1997-12-19 1998-12-18 Transvascular delivery of a composition to an extravascular tissue of a mammal

Country Status (5)

Country Link
EP (1) EP1041882A4 (en)
JP (1) JP4299967B2 (en)
AU (1) AU774299B2 (en)
CA (1) CA2314905A1 (en)
WO (1) WO1999031982A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627616B2 (en) 1995-12-13 2003-09-30 Mirus Corporation Intravascular delivery of non-viral nucleic acid
US6379966B2 (en) 1999-02-26 2002-04-30 Mirus Corporation Intravascular delivery of non-viral nucleic acid
EP1331950B1 (en) 2000-10-13 2009-10-14 The Johns Hopkins University Ex vivo methods and compositions for nucleic acid delivery
US7589059B2 (en) 2002-07-26 2009-09-15 Roche Madison Inc. Delivery of molecules and complexes to mammalian cells in vivo
US20070073264A1 (en) 2003-09-26 2007-03-29 The Trustees Of The University Of Pennsylvania Methods, compositions and apparatus for delivering heterologous molecules to cells
AR047658A1 (en) 2004-02-03 2006-02-01 Cargill Inc CONCENTRATE OF PROTEINS AND WATER CURRENT WITH HYDROSOLUBBLE CARBOHYDRATES
US7722596B2 (en) 2004-02-26 2010-05-25 Osprey Medical, Inc. Regional cardiac tissue treatment
EP1735037B1 (en) * 2004-02-26 2015-05-20 Osprey Medical Inc. Isolating cardiac circulation
JP4564052B2 (en) 2004-04-08 2010-10-20 サンガモ バイオサイエンシズ インコーポレイテッド Methods and compositions for modulating myocardial contractility
US20090054823A1 (en) 2004-09-30 2009-02-26 The Trustees Of The University Of Pennsylvania Perfusion circuit and use therein in targeted delivery of macromolecules
WO2007067502A2 (en) 2005-12-05 2007-06-14 The Trustees Of The University Of Pennsylvania Cardiac targeted delivery of cells
US8152786B2 (en) 2006-11-07 2012-04-10 Osprey Medical, Inc. Collection catheter and kit
US9050400B2 (en) 2008-08-12 2015-06-09 Osprey Medical, Inc. Remote sensing catheter system and methods
US9295816B2 (en) 2009-12-09 2016-03-29 Osprey Medical, Inc. Catheter with distal and proximal ports
EP2741804B1 (en) 2011-08-11 2017-04-26 Osprey Medical Inc. Systems and methods for limb treatment
CA3209779A1 (en) 2021-02-01 2022-08-04 Regenxbio Inc. Gene therapy for neuronal ceroid lipofuscinoses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433700A (en) * 1992-12-03 1995-07-18 Stanford Surgical Technologies, Inc. Method for intraluminally inducing cardioplegic arrest and catheter for use therein
US5478309A (en) * 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384128A (en) * 1993-03-02 1995-01-24 University Of Alabama Research Foundation Method of and compounds for treatment for cystic fibrosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433700A (en) * 1992-12-03 1995-07-18 Stanford Surgical Technologies, Inc. Method for intraluminally inducing cardioplegic arrest and catheter for use therein
US5478309A (en) * 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery

Also Published As

Publication number Publication date
EP1041882A1 (en) 2000-10-11
CA2314905A1 (en) 1999-07-01
WO1999031982A1 (en) 1999-07-01
JP2001526071A (en) 2001-12-18
AU774299B2 (en) 2004-06-24
AU2201399A (en) 1999-07-12
JP4299967B2 (en) 2009-07-22

Similar Documents

Publication Publication Date Title
EP1041882A4 (en) Transvascular delivery of a composition to an extravascular tissue of a mammal
ZA9810217B (en) New composition of matter
ZA984127B (en) New composition of matter
IL134901A0 (en) Insoluble insulin compositions
IL136551A0 (en) Preparation of peg-grf conjugates
PL339919A1 (en) Stable cosmetic compositions
GB9704989D0 (en) Improvements relating to hard-surface cleaning compositions
AU1383897A (en) Use of a combination of silicone compounds as a coupling agent in silica-loaded elastomer compositions
PL338186A1 (en) Beneficial agent compositions containing alpha-hydroxyesters
PL336724A1 (en) Pourable compositions of alginates
EP0976407A4 (en) Antiseptic composition
AUPO557497A0 (en) Improvements to underpants
HUP0000617A3 (en) Material intended to remineralise organomineral tissues
IL134249A0 (en) Collagen type i and type iii adhesive compositions
AU9042498A (en) Composition to protect a mammal against (bartonella henselae) infection
AU9061798A (en) Protease variants and compositions
AU8671798A (en) Methods and compositions relating to no-mediated cytotoxicity
AU8465998A (en) Use of oxidised polysaccharides in detergent compositions
ZA988662B (en) Storage-stable hemoglobin compositions
ZA988580B (en) Stable thickened bleaching compositions
AU2293497A (en) Detergent compositions for enhanced delivery of functional ingredients
AU1408499A (en) Compositions and methods to prevent turkey enteritis
AU9061898A (en) Protease variants and compositions
ZA981305B (en) Denture cleansing composition
LT97046A (en) Composition of aperitive ingredients

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000713

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61M 1/10 A, 7A 61M 25/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020301

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040722

RTI1 Title (correction)

Free format text: CARDIAC ISOLATION CATHETER AND KIT

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070626